- Home
- ARL vs WHWK Comparison
ARL vs WHWK Comparison
Compare ARL & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARL | WHWK |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building operators | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 256.7M | 213.2M |
| IPO Year | 1999 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ARL | WHWK |
|---|---|---|
| Price | $16.72 | $3.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 4.0K | ★ 227.9K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 206.59 | 86.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $50,014,000.00 | $7,145,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 5.70 | N/A |
| 52 Week Low | $12.42 | $1.87 |
| 52 Week High | $24.44 | $5.50 |
Technical Indicators
Market Signals| Indicator | ARL | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 52.90 | 38.60 |
| Support Level | $14.45 | $3.70 |
| Resistance Level | $16.91 | $4.38 |
| Average True Range (ATR) | 0.60 | 0.15 |
| MACD | 0.06 | -0.03 |
| Stochastic Oscillator | 71.04 | 27.59 |
Price Performance
Historical ComparisonAbout ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments: the acquisition, development, ownership and management of multifamily properties (Residential Segment) and the acquisition, ownership and management of commercial real estate properties (Commercial Segment). Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.